Showing 1 - 3 results of 3 for search 'Mary Jane Cadatal', query time: 0.04s Refine Results
  1. 1
    Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis

    Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized c... by Dafna D. Gladman, Peter Nash, Philip J. Mease, Oliver FitzGerald, Stephanie Duench, Mary Jane Cadatal, Karim R. Masri

    Published 2024-12-01
    Get full text
    Article
  2. 2
    Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance

    Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance by Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk, Magdalena Kosydar-Piechna, Mary Jane Cadatal, Jose L. Rivas

    Published 2024-07-01
    Get full text
    Article
  3. 3
    Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension

    Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension by Dafna D Gladman, Lihi Eder, Vibeke Strand, David Gruben, Alexis Ogdie, Ari Polachek, Philip Mease, Sibel Z Aydin, Cassandra Kinch, Remy A Pollock, Rayana Luna, Mary Jane Cadatal

    Published 2023-03-01
    Get full text
    Article

Search Tools: